Last reviewed · How we verify

NCT05512611

Photoplethysmography for Diagnose Incipient Hypovolemia

Completed Last updated 1 March 2023
What this trial tests

trial testing Finger photoplethysmography in Hypovolemia in 60 participants. Completed in 28 February 2023.

Timeline
15 August 2022
Primary endpoint
28 February 2023
28 February 2023

Quick facts

Lead sponsorHospital Privado de Comunidad de Mar del Plata
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date15 August 2022
Primary completion28 February 2023
Estimated completion28 February 2023
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Privado de Comunidad de Mar del Plata

Who can join

Adults 18 to 65, any sex, with Hypovolemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypovolemia caused by acute bleeding increased morbi-mortality in emergency and operatin rooms. Precise real-time diagnosis of incipient acute hypovolemia is lacking at the bedside. We hypothesize that the infrared-red signals of pulse oximetry are sensitive to acute changes in patient's volemia. We aimed to test this hypothesis in a cohort of healthy blood donors as a model of simulated acute hypovolemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Finger photoplethysmography

Trials testing the same drug.

Other recruiting trials for Hypovolemia

Currently open trials in the same condition.

Other Hospital Privado de Comunidad de Mar del Plata trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05512611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing